The [173-196] fragment of ovalbumin suppresses ovalbumin-specific rat IgE responses

International Immunopharmacology

Volumn 3, Issue 12, 2003, Pages 1569-1579

  Nasser, Imed Ben ^a,b   Boyaka, Prosper N ^c   Aissa, Fatma Fennira Ben ^d   Jeddi, Moncef ^b   Tome, Daniel ^a  

^a AGROPARISTECH   (France)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

IgE; nOVA; Peptides; Rat; T cells; Tolerance

Indexed keywords

CYTOKINE; FOOD ALLERGEN; IMMUNOGLOBULIN E; OVALBUMIN;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION; CELL SPECIFICITY; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; LIQUID CHROMATOGRAPHY; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT; T LYMPHOCYTE;

EID: 0141749371     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00164-4     Document Type: Article

References (37)

1. Carbone F.R., Bevan M.J. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169:1989;603-612.
2. Porgador A., Staats H.F., Faiola B., Gilboa E., Palker T.J. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. J. Immunol. 158:1997;834-841.
3. Belyakov I.M., Ahlers J.D., Clements J.D., Strober W., Berzofsky J.A. Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL. J. Immunol. 165:2000;6454-6462.
4. Sayegh M.H., Khoury S.J., Hancock W.W., Weiner H.L., Carpenter C.B. Mechanisms of oral tolerance by MHC peptides. Ann. N.Y. Acad. Sci. 778:1996;338-345.
5. Fritsche R., Pahud J.J., Pecquet S., Pfeifer A. Induction of systemic immunologic tolerance to beta-lactoglobulin by oral administration of a whey protein hydrolysate. J. Allergy Clin. Immunol. 100:1997;266-273.
6. Pecquet S., Bovetto L., Maynard F., Fritsche R. Peptides obtained by tryptic hydrolysis of bovine beta-lactoglobulin induce specific oral tolerance in mice. J. Allergy Clin. Immunol. 105:2000;514-521.
7. Honma K., Kohno Y., Saito K., Shimojo N., Horiuchi T., Hayachi H.et al. Allergenic epitopes of ovalbumin (OVA) in patients with hen's egg allergy: inhibition of basophil histamine release by haptenic ovalbumin peptide. Clin. Exp. Immunol. 103:1996;446-453.
8. Finkelman F.D., Holmes J., Katona I.M., Urban J.F. Jr., Beckman M.P., Park L.S.et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:1990;303-333.
9. Oettgen H.C. Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of epsilon germline transcripts. Curr. Opin. Immunol. 12:2000;618-623.
10. Shimojo N., Katsuki T., Coligan J.E., Nishimura Y., Sasazuki T., Tsunoo H.et al. Identification of the disease-related T cell epitope of ovalbumin and epitope-targeted T cell inactivation in egg allergy. Int. Arch. Allergy Immunol. 105:1994;155-161.
11. Holen E., Elsayed S. Specific T cell lines for ovalbumin, ovomucoid, lysozyme and two OA synthetic epitopes, generated from egg allergic patients' PBMC. Clin. Exp. Allergy. 26:1996;1080-1088.
12. Berkower I., Buckenmeyer G.K., Gurd F.R., Berzofsky J.A. A possible immunodominant epitope recognized by murine T lymphocytes immune to different myoglobins. Proc. Natl. Acad. Sci. U. S. A. 79:1982;4723-4727.
13. Berkower I., Matis L.A., Buckenmeyer G.K., Gurd F.R., Longo D.L., Berzofsky J.A. Identification of distinct predominant epitopes recognized by myoglobin-specific T cells under the control of different Ir genes and characterization of representative T cell clones. J. Immunol. 132:1984;1370-1378.
14. Shimonkevitz R., Colon S., Kappler J.W., Marrack P., Grey H.M. Antigen recognition by H-2-restricted T cells: II. A tryptic ovalbumin peptide that substitutes for processed antigen. J. Immunol. 133:1984;2067-2074.
15. Adorini L., Harvey M.A., Miller A., Sercarz E.E. Fine specificity of regulatory T cells: II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. J. Exp. Med. 150:1979;293-306.
16. Corradin G., Chiller J.M. Lymphocyte specificity to protein antigens: II. Fine specificity of T-cell activation with cytochrome c and derived peptides as antigenic probes. J. Exp. Med. 149:1979;436-447.
17. Hoyne G.F., O'Hehir R.E., Wraith D.C., Thomas W.R., Lamb J.R. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med. 178:1993;1783-1788.
18. Norman P.S., Ohman J.L. Jr., Long A.A., Creticos P.S., Gefter M.A., Shaked Z.et al. Treatment of cat allergy with T-cell reactive peptides. Am. J. Respir. Crit. Care Med. 154:1996;1623-1628.
19. Muller U., Akdis C.A., Fricker M., Akdis M., Blesken T., Bettens F.et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J. Allergy Clin. Immunol. 101:1998;747-754.
20. Oldfield W.L., Kay A.B., Larche M. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J. Immunol. 167:2001;1734-1739.
21. Van Der Wiele F.C., Dekker N., Van Scharrenburg G.J., Haartskeerl R.A., Meijer H., De Haas G.H.et al. Effect of selective chemical modification and CNBr-cleavage at methionine20 in catalytic activity and substrate binding properties of porcine pancreatic phospholipase A2. Biochimie. 70:1988;1215-1222.
22. Coste M., Rochet V., Leonil J., Molle D., Bouhallab S., Tome D. Identification of C-terminal peptides of bovine beta-casein that enhance proliferation of rat lymphocytes. Immunol. Lett. 33:1992;41-46.
23. Tarr G.E. Improved manual sequencing methods. Methods Enzymol. 47:1977;335-357.
24. Beauvallet C., Hountondji C., Schmitter J.M. Analytical strategy for determination of active site sequences in aminoacyl-tRNA synthetases. J. Chromatogr. 438:1988;347-357.
25. Corradin G., Etlinger H.M., Chiller J.M. Lymphocyte specificity to protein antigens: I. Characterization of the antigen-induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice. J. Immunol. 119:1977;1048-1053.
26. Leclerc C., Morin A., Deriaud E., Chedid L. Inhibition of human IL 2 production by MDP and derivatives. J. Immunol. 133:1984;1996-2000.
27. Ovary Z., Caiazza S.S., Kojima S. PCA reactions with mouse antibodies in mice and rats. Int. Arch. Allergy Appl. Immunol. 48:1975;16-21.
28. Nisbet A.D., Saundry R.H., Moir A.J., Fothergill L.A., Fothergill J.E. The complete amino-acid sequence of hen ovalbumin. Eur. J. Biochem. 115:1981;335-345.
29. Liarakos C.D., Maddox R.P., Hilscher K.A., Bishop J.R. III, McGuire D.K., Kopper R.A. Determination of secondary structure in the initiation region of ovalbumin mRNA. Nucleic Acids Res. 16:1988;11249-11265.
30. Elsayed S., Holen E., Haugstad M.B. Antigenic and allergenic determinants of ovalbumin: II. The reactivity of the NH2 terminal decapeptide. Scand. J. Immunol. 27:1988;587-591.
31. Johnsen G., Elsayed S. Antigenic and allergenic determinants of ovalbumin: III. MHC Ia-binding peptide (OA 323-339) interacts with human and rabbit specific antibodies. Mol. Immunol. 27:1990;821-827.
32. Elsayed S., Hammer A.S., Kalvenes M.B., Florvaag E., Apold J., Vik H. Antigenic and allergenic determinants of ovalbumin: I. Peptide mapping, cleavage at the methionyl peptide bonds and enzymic hydrolysis of native and carboxymethyl OA. Int. Arch. Allergy Appl. Immunol. 79:1986;101-107.
33. Moore M.W., Carbone F.R., Bevan M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 54:1988;777-785.
34. Matis L.A., Glimcher L.H., Paul W.E., Schwartz R.H. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc. Natl. Acad. Sci. U. S. A. 80:1983;6019-6023.
35. Ceredig R., Corradin G. High antigen concentration inhibits T cell proliferation but not interleukin 2 production: examination of limiting dilution microcultures and T cell clones. Eur. J. Immunol. 16:1986;30-34.
36. Suzuki G., Kawase Y., Koyasu S., Yahara I., Kobayashi Y., Schwartz R.H. Antigen-induced suppression of the proliferative response of T cell clones. J. Immunol. 140:1988;1359-1365.
37. Berzofsky J.A. Features of T-cell recognition and antigen structure useful in the design of vaccines to elicit T-cell immunity. Vaccine. 6:1988;89-93.